Sabra Health Care REIT (SBRA) Net Margin (2012 - 2026)

Sabra Health Care REIT's Net Margin history runs 15 years deep, the most recent figure standing at 17.54% for Q1 2026.

• On a quarterly basis, Net Margin fell 430.0% year-over-year to 17.54% in Q1 2026; TTM through Mar 2026 was 50.63%, a 2312.0% increase from a year earlier, with the FY2025 full-year figure at 42.47%, down 219.0% from the prior year.
• Net Margin improved to 17.54% in Q1 2026 per SBRA's latest filing, from 12.39% in the prior quarter.
• Across five years, Net Margin topped out at 102.79% in Q1 2022 and bottomed at 32.45% in Q3 2022.
• The 5-year median for Net Margin is 16.1% (2024), against an average of 19.33%.
• Across the five-year window, Net Margin soared 7755 bps in 2022 and sank 11804 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 6.39% in 2022, then slumped by 41 bps to 3.79% in 2023, then surged by 1506 bps to 60.87% in 2024, then tumbled by 120 bps to 12.39% in 2025, then surged by 242 bps to 17.54% in 2026.
• Per Business Quant, the three latest SBRA Net Margin figures stand at 17.54% (Q1 2026), 12.39% (Q4 2025), and 23.14% (Q3 2025).